FDA grants first-ever marketing authorization for ZYN nicotine pouches following a scientific review that showed lower health risks compared to traditional tobacco products and minimal youth usage.
Discover how automated EHR-driven systems significantly improved depression screening rates for youth with childhood-onset systemic lupus erythematosus in a pediatric rheumatology clinic.
Denture use was associated with better baseline cognitive function and a slower annual decline in cognitive function among older adults with partial tooth loss, suggesting prosthodontic rehabilitation may help preserve cognitive health.
Mineralys Therapeutics receives FDA clearance for a phase II clinical trial investigating lorundrostat, an aldosterone synthase inhibitor, in patients with moderate-to-severe obstructive sleep apnea and hypertension.
"Ongoing monitoring, not only of disease-specific activity but also of mental health, is essential for ensuring optimal and holistic care of chronically ill patients."
Explore the latest transcranial magnetic stimulation guidelines for depression, including updated protocols, safety data, and tailored recommendations for clinicians.
Researchers are conducting the Moore4Medical trial to evaluate whether an eHealth intervention, consisting of a wrist device and a mobile application, can effectively manage blood pressure, sleep quality, and physical activity levels in adult patients with moderate obstructive sleep apnea and hypertension.